27 June 2024
Retirement of Anita Baldauf
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) independent director Anita Baldauf has announced her intention not to seek re-election and to retire as a director of the company at the upcoming shareholders meeting on Friday 2nd August 2024.
Chair David Flacks said: “On behalf of the Board, I would like to sincerely thank Anita for her valuable contribution and service during her four-year tenure. Her industry knowledge and international finance and marketing experience has been of great assistance to AFT particularly in its continued growth internationally.”
The Board will now commence a recruitment process for a replacement director, and further details will be announced in due course.
Released for and on behalf of AFT Pharmaceuticals limited by Malcolm Tubby, Chief Financial Officer.
For more information:
Investors Media
Dr Hartley Atkinson Richard Inder
Managing Director The Project
AFT Pharmaceuticals Tel: +64 21 645 643
Tel: +64 9488 0232
About AFT Pharmaceuticals (ASX:AFP, NZX:AFT)
www.aftpharm.com
AFT Pharmaceuticals are a growing multinational pharmaceutical company that develops, markets, and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over the counter, prescription, and hospital. AFT Pharmaceutical's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded, and generic drugs.
The S&P/NZX 50 Index closed at 11,790.92, up 14.18 points or 0.12%.
US private equity giant says NZ key market for growth.
The index was down 6.9%.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details